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ABSTRACT
Introduction: Components other than the active
ingredients of treatment can have substantial effects on
pain and disability. Such ‘non-specific’ components
include: the therapeutic relationship, the healthcare
environment, incidental treatment characteristics,
patients’ beliefs and practitioners’ beliefs. This study
aims to: identify the most powerful non-specific
treatment components for low back pain (LBP),
compare their effects on patient outcomes across
orthodox (physiotherapy) and complementary
(osteopathy, acupuncture) therapies, test which
theoretically derived mechanistic pathways explain the
effects of non-specific components and identify
similarities and differences between the therapies on
patient–practitioner interactions.
Methods and analysis: This research comprises a
prospective questionnaire-based cohort study with a
nested mixed-methods study. A minimum of 144
practitioners will be recruited from public and private
sector settings (48 physiotherapists, 48 osteopaths
and 48 acupuncturists). Practitioners are asked to
recruit 10–30 patients each, by handing out invitation
packs to adult patients presenting with a new episode
of LBP. The planned multilevel analysis requires a
final sample size of 690 patients to detect correlations
between predictors, hypothesised mediators and the
primary outcome (self-reported back-related disability
on the Roland-Morris Disability Questionnaire).
Practitioners and patients complete questionnaires
measuring non-specific treatment components,
mediators and outcomes at: baseline (time 1: after
the first consultation for a new episode of LBP),
during treatment (time 2: 2 weeks post-baseline)
and short-term outcome (time 3: 3 months post-
baseline). A randomly selected subsample of
participants in the questionnaire study will be invited
to take part in a nested mixed-methods study of
patient–practitioner interactions. In the nested
study, 63 consultations (21/therapy) will be audio-
recorded and analysed quantitatively and qualitatively,
to identify communication practices associated with
patient outcomes.
Ethics and dissemination: The protocol is
approved by the host institution’s ethics committee
and the NHS Health Research Authority Research
Ethics Committee. Results will be disseminated via
peer-reviewed journal articles, conferences and a
stakeholder workshop.
INTRODUCTION
Components other than the active ingredi-
ents of treatment can have substantial effects
on pain and disability. For example, placebo
controls in osteoarthritis trials produce a
Strengths and limitations of this study
▪ This study compares multiple non-specific com-
ponents of treatment to identify those most
strongly associated with patient health
outcomes.
▪ Including multiple therapies enables new com-
parisons of non-specific components of treat-
ment across different therapies.
▪ The nested mixed-methods study will generate
new insight into patient–practitioner communica-
tion in low back pain and how it differs by thera-
peutic modality.
▪ Practitioners and patients are recruited from
diverse settings across the UK, enhancing gener-
alisability of the findings.
▪ The observational design not only means that
non-specific treatment components are being
studied as they occur in everyday clinical practice
(high ecological/external validity) but also means
that causal relationships between variables will
not be demonstrated.
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moderate effect size (0.5) on pain compared to a small
effect size (0.03) of no-treatment controls.1 Such compo-
nents have been termed ‘non-speciﬁc’2 and comprise
the broad constellation of psychological, social and
environmental factors that act alongside and can interact
with the ‘speciﬁc’ ingredients of treatment. This paper
presents a protocol for a mixed-methods cohort study to
investigate and compare non-speciﬁc components in
physiotherapy, osteopathy and acupuncture for patients
with low back pain (LBP). The purpose is to identify the
most powerful non-speciﬁc components in a naturalistic
setting and provide a deeper understanding of the path-
ways through which non-speciﬁc components generate
positive patient outcomes. This is an essential prerequis-
ite for designing interventions to augment non-speciﬁc
components and thus enable existing therapies to
deliver maximal patient beneﬁt.
Five domains of non-speciﬁc components have been
proposed: patient–practitioner interaction and relation-
ship, healthcare environment, incidental characteristics
of treatment, patients’ beliefs and practitioners’ beliefs.3
Evidence suggests that components from each of these
domains might mediate or enhance patient outcomes in
musculoskeletal and other conditions, as follows. Positive
and empathetic patient–practitioner relationships and a
strong patient–practitioner alliance are associated with
improved patient outcomes.3–6 Different healthcare set-
tings foster different patient and practitioner beha-
viours7–10 and inﬂuence the magnitude of placebo
effects.11 12 For example, in hospitals, good organisa-
tional environments (eg, collegiate working relation-
ships) enhance patient satisfaction13 and the physical–
sensory environment (eg, music) can reduce patient
anxiety, but evidence is limited and more studies are
needed in other settings.14 15 Incidental characteristics
of treatment such as the number and/or size of pills,
colour and cost of medications inﬂuence outcomes, but
equivalent characteristics in non-pharmacological inter-
ventions are not well understood.16–18 Patients can
experience better treatment outcomes when they have
higher expectations of their treatment, believe it to be
more credible and adhere to instructions to take medi-
cations, therapies, exercises or indeed placebos.19–23
Musculoskeletal practitioners differ in their beliefs about
pain24 and these beliefs affect clinical practice25
although individual differences in effect between practi-
tioners have not been well modelled and are difﬁcult to
investigate.26–28
Complementary and alternative medicine (CAM) prac-
tices and practitioners might be particularly skilled at
augmenting the context of treatment and thus enhan-
cing patient outcomes.29 In particular, patient–practi-
tioner interactions and relationships may be particularly
well developed and effective in CAM. For example, the
consultation process (alone, but in the context of a
placebo or sham treatment) is effective in acupuncture
for irritable bowel syndrome30 and homeopathy for
rheumatoid arthritis.31 CAM therapies might also
enhance patient outcomes through other so-called non-
speciﬁc domains. The ritualistic performances involved
in different CAM treatments, such as the paraphernalia
around needling in acupuncture, may also contribute to
their effects.32 Patients’ and practitioners’ belief in their
chosen CAM therapy and their broader motivations also
appear important.24 33–36 For example, the effects of
acupuncture are partially mediated by psychological
factors implicated in the maintenance of musculoskel-
etal pain, including self-efﬁcacy for coping and fear
avoidance beliefs.37
Some aspects of patient–practitioner interactions are
integral and speciﬁc to particular CAM therapies as they
operate via theoretically deﬁned, therapy-speciﬁc
mechanisms: Examples from acupuncture include trad-
itional diagnostic techniques, talk about traditional acu-
puncture models for understanding pain and the
associated, theoretically driven, lifestyle advice that acu-
puncturists offer.38–42 Qualitative studies illustrate how
homeopaths and acupuncturists communicate empathet-
ically within consultations to empower and support
patients to cope with illness and thus encourage positive,
theoretically driven, lifestyle changes.43–45 Thus non-
speciﬁc components of CAM (such as supportive
patient–practitioner relationships) may inﬂuence patient
outcomes at least in part by augmenting the speciﬁc
effects of theoretically driven treatment components.
The healthcare environment probably contributes to
the strong non-speciﬁc components attributed to CAM.
Much CAM research has been conducted in private
sector (or clinical trial) settings, which may be inher-
ently better able to augment non-speciﬁc treatment
components than public sector settings. For example,
qualitative evidence suggests that private settings facili-
tate clinical autonomy, support longer consultation
times and shorter waiting lists, engender more con-
sumerist and/or collaborative relationships, and provide
more attractive and convenient physical environments
compared to public sector settings.8 9 However, health-
care sector might not have a uniform inﬂuence on clin-
ical practice across therapies. For example, osteopaths
(but not physiotherapists) working in the National
Health Service (NHS) retained some positive non-
speciﬁc components more characteristic of the private
sector, such as mutualistic and supportive therapeutic
relationships and longer consultation times.10 Thus NHS
environments might create larger differences between
CAM and orthodox therapies than do exist in private
sector environments. While the UK-BEAM study found
no effect of the healthcare sector on exercise and
manipulation outcomes,46 the clinical trial setting might
have dominated the organisational context and con-
cealed any effects of sector.7
Overall the evidence suggests that non-speciﬁc compo-
nents can enhance patient outcomes and CAMs may be
potent at optimising non-speciﬁc components. However,
most studies have focused on one or two components,
meaning that we do not understand their relative
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importance or how they interact with each other. Most
studies have focused on a single therapy, which makes it
difﬁcult to be conﬁdent that the effects are indeed due
to non-speciﬁc components shared across therapies
rather than being intimately entwined with a particular
therapy’s theoretical framework.38 There is also a need
for more theoretical work explaining how non-speciﬁc
components elicit positive effects.47 48 This study there-
fore aims to examine non-speciﬁc components from
multiple domains across multiple treatments, within the
context of an overarching theoretical framework, which
was derived from the literature.
Theoretical framework
Figure 1 presents the theoretical framework for this
study. The patient is at the centre of this model: non-
speciﬁc components lead to reductions in self-reported
pain and disability through their impact on the patients’
pain cognitions/emotions and behaviours. In particular,
we hypothesise that non-speciﬁc treatment components
affect patient outcomes by (1) triggering changes in
patients’ cognitive and affective states involved in the
maintenance of pain, such as fear avoidance beliefs
and/or (2) affecting patients’ self-efﬁcacy for coping
with their pain, and/or (3) inﬂuencing patients’ health
behaviours such as physical activity, diet and coping.
These mechanisms may themselves be common across
therapies (eg, a direct effect of positive expectations on
reported pain outcomes) or may operate via an inter-
action between non-speciﬁc and speciﬁc components of
treatment (eg, positive expectations lead to patients
having a better understanding of the treatment-speciﬁc
explanations, which then leads to increased uptake of
theoretically driven lifestyle advice).
The next layer in the model is the patient–practitioner
relationship, two key components of which are commu-
nication style and therapeutic alliance. We hypothesise
that positive patient–practitioner relationships engender
supportive self-care communication and shared goals,
which then trigger adaptive changes such as increased
self-efﬁcacy for coping and uptake of lifestyle advice.
This process has been illustrated qualitatively in acu-
puncture.44 For example, when a practitioner communi-
cates in a patient-centred empathetic way, a patient will
feel respected and understood and will experience a
supportive bond with their therapist. The patient will be
more likely to believe the practitioner’s claims that their
pain is manageable and to share ownership of the treat-
ment plan, resulting in improved pain beliefs, increased
self-efﬁcacy for coping with pain and uptake of lifestyle
advice. The interactions between the therapeutic rela-
tionship and patients’ beliefs are probably bidirectional:
evidence from psychotherapy suggests that the effect of
patients’ expectations on outcomes is partially mediated
by the therapeutic relationship.49 50 In other words,
patients who expect therapy to be successful are more
open to developing positive patient–practitioner rela-
tionships which go on to augment therapy outcomes.
The patient–practitioner relationship is itself partially
determined by the individual practitioner, the next layer
in the model. Practitioners’ beliefs about the nature of
back pain have been shown to inﬂuence their clinical
decision-making.24 25 We hypothesise that practitioners’
beliefs about back pain also inﬂuence their communica-
tion style. For example, practitioners who have a more
biomedical model of back pain are probably less likely
to engage in psychosocial talk and hence may be less
likely to inﬂuence patients’ pain-related affect and
cognitions.
Finally, the outer layer of the model comprises the
healthcare environment in which the practitioner and
patient interact. Environmental factors are hypothesised
to affect patients’ outcomes via their impact on the prac-
titioner’s behaviour, the therapeutic relationship and the
patients themselves. For example, organisational con-
straints in the NHS encourage managed care, can dis-
courage some practitioners from taking holistic
treatment orientations and can foster paternalistic thera-
peutic relationships, thus reducing patients’ sense of
control.8 9 51
Setting
This project uses LBP as a model for studying non-
speciﬁc treatment components and processes because:
LBP is highly prevalent,52 there is no gold-standard treat-
ment and existing treatments provide only modest
relief,53 54 meaning an exploration of non-speciﬁc com-
ponents offers an opportunity to enhance existing
Figure 1 Multilevel framework of
non-specific treatment
components.
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treatments. Furthermore, pain theories (eg, fear avoid-
ance model55) provide an excellent biopsychosocial
framework to inform an understanding of how non-
speciﬁc components trigger effects. Finally, orthodox
and CAM approaches are popular in patients with LBP
and are recommended in clinical guidelines,56–60 enab-
ling comparisons between orthodox and CAM therapies.
We have chosen to focus on physiotherapy (orthodox),
osteopathy (CAM) and traditional acupuncture (CAM)
as these are commonly used by patients with painful
conditions60–62 and are recommended in clinical guide-
lines for the management of LBP.56 They have distinct
theoretical and explanatory frameworks but all involve
some hands-on treatment, a series of treatments over
time allowing for the development of a patient–practi-
tioner relationship and an element of patient education
regarding self-management.
Aims
The aims are to:
1. Identify the most powerful non-speciﬁc treatment
components (ie, those that have the largest effect on
patient outcomes).
2. Compare the magnitude of non-speciﬁc effects across
orthodox (physiotherapy) and CAM (osteopathy, acu-
puncture) therapies.
3. Test whether theoretically derived mechanistic path-
ways explain the effects of non-speciﬁc components.
4. Identify similarities and differences in patient–practi-
tioner interactions across the three therapies.
The associated hypotheses are presented in table 1.
METHODS AND ANALYSIS
This research comprises a prospective questionnaire-
based cohort study with a nested mixed-methods study.
The questionnaire-based study addresses aims 1–3. The
nested mixed-methods study addresses aim 4. The
questionnaire-based study collects self-report data from a
large number of patients and practitioners and tests the
effects of non-speciﬁc components from all ﬁve
domains. The nested mixed-methods study conducts
qualitative and quantitative analyses of a small sample of
audio-recorded patient–practitioner interactions, to
complement the self-report methods and broader focus
of the questionnaire-based study.
Prospective questionnaire-based cohort study
Design
Practitioners and patients complete questionnaires at
three time points: baseline (T1: after the ﬁrst consult-
ation for a new episode of LBP), during treatment (T2:
2 weeks post-baseline) and short-term outcome (T3:
3 months post-baseline) (ﬁgure 2). Non-speciﬁc factors
are measured once with time points chosen to reduce
ceiling effects, capture data accurately and spread the
questionnaire burden. Outcomes, prognostic indicators
Table 1 Aims and hypotheses
Aim Associated hypotheses
1. Identify the most powerful non-specific
treatment components (ie, those that have
the largest effect on patient outcomes)
Patients experience less back-related disability after treatment for LBP when
non-specific components are more positive, ie, when:
A. The therapeutic alliance is stronger and practitioner communication is
more patient-centred
B. The healthcare environment is experienced by patients as pleasant,
accessible and convenient, and by practitioners as supportive
C. Appointment duration is longer
D. Patients expect their treatment to be effective, perceive it as credible and
suitable for them personally and have few concerns about it
E. Practitioners have a biopsychosocial orientation to back pain and expect
patients to respond well to treatment
2. Compare the magnitude of non-specific
effects across orthodox (physiotherapy) and
CAM (osteopathy, acupuncture) therapies
A. CAM therapies (acupuncture and osteopathy) produce larger non-specific
effects than orthodox therapy (physiotherapy)
B. Differences between therapies are more pronounced in the NHS than in
the private sector8–10
3. Test that theoretically derived mechanistic
pathways explain the effects of non-specific
components
Non-specific components reduce patients’ back-related disability via:
A. Improvements in patients’ pain beliefs (eg, reduced fear of pain)
B. Increases in patients’ self-efficacy for coping with pain
C. Increased implementation of theory-specific lifestyle advice
4. Identify similarities and differences in
patient–practitioner interactions across the
three therapies
A. Acupuncture and osteopathy consultations score higher than
physiotherapy consultations on an index of ‘patient-centeredness’
B. Patients who receive consultations that score higher on the patient-
centeredness index report more positive outcomes than patients who
receive consultations that score lower on the patient-centeredness index
C. Consultations in the private sector score higher than those in the NHS on
the patient-centeredness index12–14
CAM, complementary and alternative medicine; NHS, National Health Service.
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and potential mediators are measured at T1, T2 and T3,
to permit tests of whether scores on non-speciﬁc factors
are associated with changes over time in prognostic indi-
cators or mediators. Participants can choose to complete
hard copies (mailed, returned via Freepost) or elec-
tronic copies (emailed, completed online). Online and
paper versions of our primary outcome are equivalent,
can be used interchangeably and patients value having
this choice.63
Participants
To participate, practitioners must treat at least one
patient with LBP on average per week and have at least
3 years relatively current experience in musculoskeletal
work. Osteopaths and physiotherapists must be regis-
tered with the General Osteopathic Council and
Chartered Society of Physiotherapy, respectively.
Acupuncturists must be eligible to register with the
British Acupuncture Council (BAcC) (ie, a 3-year qualiﬁ-
cation or equivalent in traditional acupuncture).
Physiotherapists who use acupuncture clinically can par-
ticipate (as physiotherapists) as this is becoming
common clinical practice.
To participate, patients must be at least 18 years old,
seeking treatment from a participating practitioner at
their ﬁrst consultation for a new episode of LBP and
score at least 4 on the Roland-Morris Disability
Questionnaire (RMDQ).64 Patients will be ineligible if
Figure 2 Study flow chart.
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they: are unable to complete questionnaires in English
or Welsh, have serious underlying pathology (inﬂamma-
tory arthritis, malignancy) or have practitioner-identiﬁed
conditions that would prevent the sought treatment
being applied. Arguably, LBP as managed in primary
care should be conceptualised as typically having a
chronic–episodic timeline with recurrent acute ﬂare-ups
against a backdrop of temporary remission or less
bothersome symptoms.65 66 Broad inclusion criteria thus
best reﬂect the clinical situation and will ensure that our
cohort is representative of patients with LBP treated by
physiotherapists, osteopaths and acupuncturists.
Sample size
Data from our earlier longitudinal questionnaire-based
study of acupuncture for LBP were used as the basis for
these sample size calculations.37 The planned multilevel
analysis requires a ﬁnal sample size of 690 patients to
detect correlations between predictors, hypothesised
mediators and the primary outcome, the RMDQ,64 with
Pearson’s R=0.2 (and corresponding β regression coefﬁ-
cients of 0.235) with 95% power and p<0.0005 (two
tailed). This sample size has been adjusted for clustering
of patients within practitioners using a factor of 1+(k
−1)×ICC, where k=8 (number of patients per practi-
tioner) and ICC=0.01 (ICC based on UK Beam67 68).
The ﬁnal sample size will also be sufﬁcient to detect,
within each therapy subgroup, correlations between the
predictors and the primary outcome of Pearson’s R=0.2,
at p<0.04 with a minimum of 81% power. This sample
size should also allow us to test for interactions and pos-
sible therapy-speciﬁc effects.
If the data are not normally distributed and transfor-
mations do not achieve a normal distribution, we will
still have sufﬁcient power to detect bivariate correlations
(eg, Spearman’s ρ=0.2) between the predictors and
the primary outcome in the whole sample (power=95%,
p<0.002) and in each therapy subgroup (power=80%,
p<0.05).
If all practitioners recruit 8 patients, then 86 practi-
tioners are needed; however, some attrition is likely. To
allow for 40% attrition of practitioners, 144 practitioners
will be recruited (48 per therapy). To allow for 30%
attrition of patients, 986 patients will be recruited.
Practitioners are asked to recruit 10–30 consecutive eli-
gible adult patients, allowing some ﬂexibility and enhan-
cing recruitment to at least the minimum level.
Measures
Table 2 summarises the chosen constructs and measures.
Outcomes
The primary outcome is self-reported back-related dis-
ability, measured using the 24-item RMDQ.64 Secondary
Table 2 Constructs and measures
Domain Construct Measure Items Time point*
Completed
by
Outcomes
Primary Disability RMDQ64 24 T1, T2, T3 Patient
Secondary Social role disability Core item69 1 T1, T2, T3 Patient
Work disability Core item69 1 T1, T2, T3 Patient
Pain Core item69 1 T1, T2, T3 Patient
Well-being Core item69 1 T1, T2, T3 Patient
Satisfaction Core item69 1 T1, T2, T3 Patient
Non-specific factors
Relationship Therapeutic alliance WAI-SF70 71 12 T2 Patient
Healthcare environment Organisational ABS-mp24 72 9 T1 Practitioner
Appointments, access, facilities PSQ73 16 T2 Patient
Treatment characteristics Modalities Single item 2 T3 per patient Practitioner
Duration Single item 1 T3 per patient Practitioner
Patient’s beliefs Treatment beliefs LBP treatment beliefs
questionnaire74
16 T1 Patient
Practitioner’s beliefs Attitudes to LBP ABS-mp24 72 12 T1 Practitioner
Outcome expectations Single item 1 T1 per patient Practitioner
Mediators/prognostic indicators
Risk complexity for recovery STarT Back75 9 T1, T2, T3 Patient
Self-efficacy Self-efficacy for pain
management76
5 T1, T2, T3 Patient
Adherence to lifestyle advice Single item 3 T1, T2, T3 Patient
Illness perceptions BIPQ77 9 T1, T2, T3 Patient
*T1=baseline (after first treatment for new episode of LBP); T2=during treatment (2 weeks post-baseline); T3=short-term outcome (3 months
post-baseline).
ABS-mp, Attitudes to Back Pain Scale—Musculoskeletal Practitioners; BIPQ, Brief Illness Perceptions Questionnaire; LBP, low back pain;
PSQ, Patient Satisfaction Questionnaire; RMDQ, Roland-Morris Disability Questionnaire; WAI-SF, Working Alliance Inventory—Short Form.
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outcomes (pain intensity, well-being, work and social
role disability, satisfaction with care) are measured using
recommended core single items.69
Patient–practitioner relationship
The patient–practitioner relationship is operationalised
as the therapeutic alliance; this construct is grounded
in theory on how patient–practitioner interactions can
elicit psychological/behavioural changes,78 consistently
predicts patient outcomes in psychotherapy5 and offers
a good ﬁt with CAM. For example, the three dimen-
sions of therapeutic alliance capture egalitarian part-
nerships, patient participation and individualised care
(as collaboration), perceived interpersonal connection
and liking (as affective bond) and new holistic insights
into illness and treatment (as concordant goals). These
aspects of the patient–practitioner relationship have
been shown to be important to CAM patients.8 27 79–83
Therapeutic alliance is assessed using the client
version of the Working Alliance Inventory—Short Form
(WAI-SF), which assesses all three dimensions of
working alliance with acceptable psychometric proper-
ties.5 70 71 The patient-rated WAI-SF may have ceiling
effects if used after one treatment but tends to remain
stable after the second treatment;5 it is therefore admi-
nistered at T2.78 84
Healthcare environment
The healthcare environment is operationalised as the
organisational environment and the sensory–physical
environment. Practitioners’ perceptions of the organisa-
tional environment are measured using two single items
to assess the caseload and waiting list and two subscales
from the psychometrically sound Attitudes to Back Pain
Scale—Musculoskeletal Practitioners (ABS-mp): putting
limits on sessions and perceived connections within the
healthcare system.24 72
Patients’ perceptions of the organisational and
sensory–physical environment are assessed using three
subscales of the Patient Satisfaction Questionnaire
designed to assess patient perceptions of the quality of
primary healthcare in the UK.73 The access subscale
measures perceptions of interactions with reception
staff; the appointment subscale measures the perceived
availability of convenient appointments; the facility sub-
scale measures perceptions of the physical environment
of the clinic and waiting room.
Characteristics of treatment
To assess the general characteristics of treatment, practi-
tioners record for each patient: the treatment given
(physiotherapy, osteopathy, acupuncture), individual
modalities used (eg, manipulation, mobilisation, need-
ling), the number of appointments attended and their
average duration. Patients report how many treatments
they have received.
Patients’ beliefs
This domain is operationalised as patients’ treatment
beliefs, measured using the brief LBP Treatment
Beliefs Questionnaire that assesses four dimensions of
treatment beliefs: perceived/anticipated effectiveness,
credibility, concerns and individualised ﬁt.74 It was
explicitly designed for use in mixed cohorts of patients
with LBP undergoing diverse treatments. This question-
naire is completed at T1 as patients’ expectations
regarding effectiveness should be measured early in
treatment.22
Practitioners’ beliefs
This domain is operationalised as practitioners’ outcome
expectations and beliefs about LBP. A single-item
numerical rating scale measures practitioners’ outcome
expectations for each patient. Four subscales from the
ABS-mp measure: willingness to engage with psycho-
logical issues, conﬁdence and concern over clinical lim-
itations, reactivation of work and activity and belief in an
underlying structural cause of pain.24 72
Prognostic indicators and mediators
The STarT Back screening tool with good predictive val-
idity is used to assess mood, fear, worry and catastrophis-
ing.75 85 86 The reliable and valid Brief Illness
Perceptions Questionnaire (BIPQ) is used to measure
eight dimensions of illness perceptions in relation to
LBP.77 Self-efﬁcacy for coping with LBP is assessed using
the ﬁve-item Chronic Pain Self-Efﬁcacy for Pain
Management subscale.76 There is no gold-standard
measure of adherence,87 and practitioners’ recommen-
dations are likely to be highly personalised to individual
patients. Adherence is therefore conceptualised in rela-
tion to three broad domains of lifestyle changes (thera-
peutic exercises, diet and physical activity) and
measured using a single item worded to reduce social
desirability bias.88 Practitioners also report whether they
gave theoretically derived lifestyle advice to each patient.
Clinical and demographic covariates
Patient-level covariates are as follows: leg pain and shoul-
der/neck pain bothersomeness (measured using STarT
Back75), duration of LBP, age, gender, work status,
compensation status, comorbidities, co-treatments and
socioeconomic status (indicated by postcode).
Practitioner-level covariates are as follows: time since
qualifying and experience in musculoskeletal care.
Procedure
Figure 2 presents the study ﬂow chart, summarising the
ﬂow of participants through the study. Physiotherapists,
osteopaths and acupuncturists working in the NHS and
the private sector throughout the UK are recruited by
advertisements (eg, online and in newsletters) and per-
sonal invitations, with support from the Clinical
Research Network, the Chartered Society of
Physiotherapy, the General Osteopathic Council and the
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BAcC. Practitioners who express an interest in taking
part are sent information and consent forms and
offered the opportunity to discuss the study with the
researchers before providing written informed consent
and completing their T1 questionnaires (see table 2).
When potentially eligible patients present for treatment,
at their ﬁrst consultation, practitioners hand them a
study invitation pack containing an invitation letter,
information sheet, consent form and T1 questionnaire.
On inviting an eligible patient into the study, practi-
tioners complete the T1 per patient questionnaire with
respect to that patient. All completed consent forms and
questionnaires are returned directly to the researchers
via prepaid envelopes. The researchers email or mail
(participant’s choice) the T2 and T3 questionnaires to
participants who again return them directly to the
researchers. If participants do not respond to T2 and/or
T3 questionnaires, the questionnaires are resent and par-
ticipants are contacted by telephone. If no contact is
forthcoming at T3, participants are invited to complete
the primary outcome measure by telephone.
The following strategies are used to enhance recruit-
ment and retention rates: monthly update emails to
practitioners, small gifts (eg, tea bag/pen) and monet-
ary incentives (£5 voucher) for patients, personalised
questionnaires, ink-signed cover letters, coloured ink,
stamped return envelopes, ﬁrst class post and follow-up
strategy for non-responders.89–91
Analysis plan
Data obtained from paper questionnaires will be input-
ted and data entry checked for accuracy (using double
entry for 10% of data). All data will be imported into
SPSS for preliminary data analysis, which will include
checking measurement properties and distributions of
questionnaire scores (performing transformations if
necessary to achieve normal distributions), examining
and dealing with missing data (eg, by multiple imput-
ation) and ensuring the data meet the assumptions of
the main analysis (eg, linear relationships between pre-
dictors and outcomes). The main analysis will be per-
formed by multilevel methods (eg, Restricted Maximum
Likelihood; REML) using appropriate statistical software
(eg, MLWin) to construct a multilevel regression model
taking into account the clustering of individual patients
within practitioners (two-level model: level
1=patients and level 2=practitioners). As a secondary
aim, the self-reported patient outcomes can be modelled
as time-varying repeated measures, while the non-
speciﬁc factors remain time-invariant predictors (three-
level model: level 1=time, level 2=patients and level
3=practitioners). We will test for main effects of the pre-
dictors (hypothesis 1), interaction effects (hypothesis 2)
and mediation effects (hypothesis 3). Multilevel model-
ling provides an ideal framework for examining such a
complex data set and testing our hypotheses, which
involve main effects as well as complex interactions
between the variables.
Nested mixed-methods study of consultations
Design
This nested study explores whether CAM and orthodox
therapists use different verbal communication styles and
the extent to which these are more or less effective. A
mixed-methods design combines qualitative and quanti-
tative analyses of audio-recorded consultations from a
random sample of participants in the questionnaire-
based study using each therapy. We have selected audio-
recording as the least intrusive and most cost-effective
method of observing a consultation, but acknowledge
that this method is limited to capturing verbal communi-
cation only. The analysis will test speciﬁc hypotheses
(see table 1), and identify similarities and differences
between acupuncture, osteopathy and physiotherapy
consultations on (1) the frequency of different types of
communication and (2) the thematic content of the
consultations.
Participants
Using random number tables, we will invite a random
sample of practitioners from the questionnaire-based
study to take part. Given qualitative evidence suggesting
that consultations in the private sector might be more
patient-centred than those in the NHS,8–10 we will stratify
for the healthcare sector.
Sample size
We will audio-record 21 consultations from each
therapy: seven therapists per therapy will record a single
consultation from each of three patients. This should
ensure that particularly unusual cases do not dominate
and is sufﬁcient to detect a large difference between the
therapies with 80% power and α=0.05. (We could locate
no previous studies comparing observed CAM and
orthodox consultations to inform a more precise power
calculation).
Procedure
Using random number tables, a random selection of
practitioners from the questionnaire-based study will be
sent information about this nested study and invited to
take part (additional informed consent is taken specif-
ically for this nested study). Consecutive eligible
patients who consult practitioners in this nested study
will be given study invitation packs including all stand-
ard documents for the questionnaire-based study and
an additional information sheet and consent form
regarding this nested study, requesting written
informed consent to audio-record a consultation. On
receiving patient consent, the researchers notify
the practitioner who audio-records the next consult-
ation using a digital audio-recorder. Patients and
practitioners then continue in the Prospective
Questionnaire-Based Cohort Study as described above
(see Figure 2).
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Analysis plan
Audio-recordings will be coded with the widely used
Roter Interactional Analysis System (RIAS),92 which has
previously been used for back pain consultations.93 94
The RIAS can be applied directly to video or audio-
recordings of consultations and requires the coder to
rate each expressed meaning with a single code. Codes
are mutually exclusive and comprehensive and incorpor-
ate task-focused and socioemotional elements of
patient–practitioner interactions. We will generate fre-
quency counts for different categories and subcategories
of utterances (eg, emotional talk, empathy and
concern).95 We will combine frequency counts and cal-
culate a ratio of patient-centred to doctor-centred talk,96
to produce a patient-centred index for each consult-
ation. A proportion of RIAS coding will be done inde-
pendently by two coders to check reliability.
A 3×2 analysis of variance (ANOVA) will test for the
effects of therapy (osteopathy, physiotherapy, acupunc-
ture) and healthcare sector (NHS, private) on patient-
centredness. Regression analyses will test whether
patient-centred communication predicts patient out-
comes (derived from the questionnaire-based study).
Inductive qualitative analysis will explore the thematic
content of talk97 and take a more holistic view of the
consultations, thus addressing some of the limitations of
relying solely on quantitative interactional analysis
systems98–100 and helping capture any unique features of
CAM consultations.
ETHICS AND DISSEMINATION
Ethics and governance
The study is conducted in accordance with the British
Psychological Society Code of Human Research Ethics,
the Helsinki Declaration, the Research Governance
Framework for Health and Social Care, the Data
Protection Act 1998 and International Conference for
Harmonisation of Good Clinical Practice (ICH GCP)
guidelines. Site-speciﬁc approvals are obtained for all
NHS sites as required. The study sponsor is the
University of Southampton.
Potential beneﬁts of taking part include the chance to
reﬂect on thoughts about treating LBP (practitioners)
and the chance to reﬂect on thoughts about LBP, treat-
ment and health in general (patients). The main disad-
vantage is the time required to complete the
questionnaires. The content of the questionnaires is
unlikely to be distressing.
Practitioners from across the UK and their patients are
invited to take part on a voluntary basis. Recruitment
material makes no therapeutic promises and there is no
coercion. Potential participants receive written informa-
tion that describes the study in detail including:
purpose, study procedures, potential risks and beneﬁts
to the participant, funding and review arrangements,
conﬁdentiality, dissemination plans, what to do if there
is a problem and contact details for further information.
They have the opportunity to discuss the study and
provide full written informed consent before being
enrolled. They have the right to withdraw from the study
at any time without giving a reason and without penalty.
All data are collected and retained in accordance with
the Data Protection Act 1998. Electronic data are stored
on University of Southampton secure research ﬁlestore.
Digital audio-recordings of consultations are password-
protected and stored securely electronically for the dur-
ation of the research; personal details are removed
during transcription. Direct quotes from the audio-
recordings will be anonymised before being published
(with consent—participants are asked for consent to
being quoted verbatim in published reports).
Anonymised data will be stored securely for a period of
10 years from study publication, in line with the host
institution’s guidance. Audio-recordings and personal
details necessary to administer the research will be
destroyed on study publication.
Small non-monetary (eg, tea bag/pen) and monetary
incentives (worth £5) are used in this study. They are
non-contingent on response and are presented as small
gifts of thanks to participants. The small absolute value
of these incentives is very unlikely to exert pressure on
potential participants to take part.
Patient public involvement
Three patient volunteers with experience of musculo-
skeletal pain and/or at least one of the treatments
under study provided feedback in the early stages of
developing this project. We have recruited one patient
volunteer to contribute to the study on an ongoing
basis. Their remit is to comment on study design and
implementation issues in order to ensure that our
project is sensitive to patients’ concerns and priorities;
in particular, to comment on all materials to be given to
patients in the studies; to assist in interpreting qualitative
themes and quantitative results; to advise on and poten-
tially contribute to dissemination activities.
Dissemination
Results will be disseminated at conferences and in peer-
reviewed journals. Regardless of the results, the ques-
tionnaire study and the nested mixed-methods study will
be published. We will also disseminate ﬁndings to all par-
ticipants, to relevant professional bodies and patient
organisations and to the general public. We will provide
personalised feedback to the practitioners in the nested
study of the consultations based on the RIAS analysis of
their communication. We will hold a stakeholder work-
shop to discuss the implications of our ﬁndings for
patients, practice and policy.
DISCUSSION
This research is examining the role of non-speciﬁc
treatment components in orthodox and CAM manage-
ment of LBP. In doing so, we will come to better
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understand the nature and effects of non-speciﬁc com-
ponents. This is a vital next step to enable research on
non-speciﬁc treatment components to contribute to
enhancing treatment to help people remain active and
pain-free. Our research will identify the most effective
non-speciﬁc treatment components in LBP and model
how they produce positive patient outcomes; this will
help practitioners, policymakers and researchers to
optimise non-speciﬁc components across diverse
therapies, thus enhancing treatments and maximising
patient beneﬁt. Depending on the results, we hope to
be able to suggest how non-speciﬁc components of
orthodox treatments will be enhanced by learning
from CAM.
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